scholarly article | Q13442814 |
P2093 | author name string | C Richard Boland | |
Henry T Lynch | |||
P2860 | cites work | Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis | Q22122362 |
Mutations of two PMS homologues in hereditary nonpolyposis colon cancer | Q24318484 | ||
Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer | Q24614511 | ||
Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability | Q24618618 | ||
Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X | Q24618839 | ||
Microsatellite instability in colorectal cancer | Q24627393 | ||
EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome | Q24655053 | ||
Mutation of a mutL homolog in hereditary colon cancer | Q28114939 | ||
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome | Q28131662 | ||
Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer | Q28253384 | ||
The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer | Q28256988 | ||
Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer | Q28257360 | ||
Genetic mapping of a locus predisposing to human colorectal cancer | Q28268634 | ||
A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer | Q28289377 | ||
GTBP, a 160-kilodalton protein essential for mismatch-binding activity in human cells | Q28292790 | ||
Mutations of GTBP in genetically unstable cells | Q28292802 | ||
The immune contexture in human tumours: impact on clinical outcome | Q29620667 | ||
Microsatellite instability in cancer of the proximal colon | Q29620692 | ||
Aberrant DNA methylation in hereditary nonpolyposis colorectal cancer without mismatch repair deficiency | Q33811768 | ||
Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer | Q33930691 | ||
Hereditary factors in cancer. Study of two large midwestern kindreds | Q34241416 | ||
Report from the Jerusalem workshop on Lynch syndrome-hereditary nonpolyposis colorectal cancer | Q34545510 | ||
Cancer family “G” revisited: 1895-1970 | Q34701495 | ||
Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome | Q34901055 | ||
Mismatch repair proficiency and in vitro response to 5-fluorouracil | Q35129256 | ||
Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial | Q35627411 | ||
Evolution of the nomenclature for the hereditary colorectal cancer syndromes | Q36246478 | ||
Lynch syndrome-associated extracolonic tumors are rare in two extended families with the same EPCAM deletion | Q37248283 | ||
Isolation and characterization of allelic losses and gains in colorectal tumors by arbitrarily primed polymerase chain reaction | Q37265131 | ||
Competency in mismatch repair prohibits clonal expansion of cancer cells treated with N-methyl-N'-nitro-N-nitrosoguanidine | Q37357197 | ||
Hereditary Nonpolyposis Colorectal Cancer: the Syndrome, the Genes, and Historical Perspectives | Q40482404 | ||
Role of hMLH1 promoter hypermethylation in drug resistance to 5-fluorouracil in colorectal cancer cell lines. | Q40582817 | ||
Conversion of diploidy to haploidy | Q40897610 | ||
The role of DNA mismatch repair in platinum drug resistance | Q41155820 | ||
Loss of DNA mismatch repair in acquired resistance to cisplatin | Q41189901 | ||
Evidence for a connection between the mismatch repair system and the G2 cell cycle checkpoint | Q41303489 | ||
Human chromosome 3 corrects mismatch repair deficiency and microsatellite instability and reduces N-methyl-N'-nitro-N-nitrosoguanidine tolerance in colon tumor cells with homozygous hMLH1 mutation | Q41448577 | ||
Hypermutability and mismatch repair deficiency in RER+ tumor cells | Q41508298 | ||
Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3' exons of TACSTD1. | Q42607034 | ||
Clues to the pathogenesis of familial colorectal cancer | Q42622043 | ||
History and molecular genetics of Lynch syndrome in family G: a century later | Q44082437 | ||
Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer | Q48084125 | ||
Origins of the Leeds Castle Polyposis Group | Q52859745 | ||
History of the International Collaborative Group on Hereditary Non Polyposis Colorectal Cancer. | Q53296714 | ||
[Familial incidence of double malignancies] | Q54447720 | ||
New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. | Q55033068 | ||
Heredity and adenocarcinoma of the colon. | Q55493966 | ||
A family history of uterine and gastro-intestinal cancer. | Q55509723 | ||
Genetic mapping of a second locus predisposing to hereditary non–polyposis colon cancer | Q58862199 | ||
Hereditary nonpolyposis colorectal cancer (lynch syndromes I and II). I. Clinical description of resource | Q62772420 | ||
Hereditary nonpolyposis colorectal cancer (lynch syndromes I and II). II. Biomarker studies | Q62772424 | ||
MSH2 genomic deletions are a frequent cause of HNPCC | Q62977773 | ||
The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC) | Q62978412 | ||
Familial colonic cancer without antecedent polyposis | Q71317779 | ||
[Hereditary nature of cancers of the colon] | Q72287592 | ||
Heredity and multiple primary malignant neoplasms: six cancer families | Q72298705 | ||
FAMILIAL CANCER OF THE COLON | Q76820704 | ||
[ON A CANCER FAMILY. A CONTRIBUTION TO THE PROBLEM OF THE HEREDITARY ASPECTS OF COLONIC CARCINOMA.] | Q77107986 | ||
DOUBLE CANCER IN SIBLINGS. FAMILIAL ASSOCIATION OF CANCER OF THE GENITALIA AND INTESTINES | Q78270857 | ||
FAMILIAL DISPOSITION OF CANCER OF THE GASTROINTESTINAL TRACT | Q78527751 | ||
P433 | issue | 2 | |
P304 | page(s) | 145-157 | |
P577 | publication date | 2013-06-01 | |
P1433 | published in | Familial Cancer | Q15761917 |
P1476 | title | The history of Lynch syndrome | |
P478 | volume | 12 |
Q47210474 | Consequences of testing for mismatch repair deficiency of colorectal cancer in clinical practice |
Q35601625 | Considerations and management of a patient with three metachronous cancers in association with Lynch syndrome and ileal Crohn's disease: A case report |
Q45718448 | Detailed characterization of MLH1 p.D41H and p.N710D variants coexisting in a Lynch syndrome family with conserved MLH1 expression tumors. |
Q37673618 | Historical Perspective on Familial Gastric Cancer. |
Q52321073 | Immunohistochemistry for mismatch repair protein deficiency in endometrioid endometrial carcinoma yields equivalent results when performed on endometrial biopsy/curettage or hysterectomy specimens. |
Q34347636 | Lynch syndrome: an updated review |
Q36319705 | Mechanisms of glycosylase induced genomic instability |
Q93079487 | Mismatch Recognition by Saccharomyces cerevisiae Msh2-Msh6: Role of Structure and Dynamics |
Q38895750 | Mismatch Repair Deficiency and Response to Immune Checkpoint Blockade |
Q36540568 | Mismatch repair defects and Lynch syndrome: The role of the basic scientist in the battle against cancer |
Q51116841 | Mismatch repair deficient-crypts in non-neoplastic colonic mucosa in Lynch syndrome: insights from an illustrative case. |
Q38262826 | Mismatch repair genes founder mutations and cancer susceptibility in Lynch syndrome. |
Q28084645 | New insights into the mechanism of DNA mismatch repair |
Q42039194 | Novel Mutations in MLH1 and MSH2 Genes in Mexican Patients with Lynch Syndrome |
Q27024662 | PMS2 monoallelic mutation carriers: the known unknown |
Q40821149 | Recent discoveries in the molecular genetics of Lynch syndrome |
Q53081522 | Recent progress in Lynch syndrome and other familial colorectal cancer syndromes. |
Q48332104 | The Changing Landscape of Lynch Syndrome due to PMS2 Mutations. |
Q34234950 | The evolution of colorectal cancer genetics-Part 2: clinical implications and applications |
Search more.